Of note, the observed performance of the CD38-based TAM assay reported here bypassed the minimal 80% sensitivity and closely reached the 98% specificity specified for the optimal Target Product Profile (TPP) prioritized by WHO for non-sputum-based TB diagnostic tests5. This evidence concerns the gene CD38 and tuberculosis.